Pfizer Pharma (Wuxi) Changes Legal Representative to Cai Fang
2026-06-24 05:52:33
Pfizer Pharma (Wuxi) Co., Ltd. has updated its company registration, with Jean-Christophe Michel Pointeau stepping down as legal representative, executive director and general manager, and Cai Fang taking over as legal representative and general manager while also serving as a director, according to 36Kr. The company was established in September 1995 with registered capital of $36 million, and its business scope includes manufacturing lyophilized powder injections and small-volume injections. It is wholly owned by Pfizer Investment Co., Ltd., the filing shows.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
